Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes
致美国食品药品监督管理局（FDA）的信函：提议对美国氯氮平药品说明书进行重大修改，该提议得到了全球氯氮平专家的支持。第一部分：药代动力学文献综述及拟议修改
期刊:Journal of Clinical Psychopharmacology
影响因子:2.8
doi:10.1097/JCP.0000000000001987
de Leon, Jose; Baldessarini, Ross J; Balon, Richard; Bilbily, John; Caroff, Stanley N; Citrome, Leslie; Correll, Christoph U; Cotes, Robert O; Davis, John M; DeLisi, Lynn E; Faden, Justin; Freudenreich, Oliver; Goldsmith, David R; Gurrera, Ronald; Josiassen, Richard C; Kane, John M; Kelly, Deanna L; Keshavan, Matcheri S; Laitman, Robert S; Lam, Y W Francis; Leung, Jonathan G; Love, Raymond C; McCollum, Betsy; McGrane, Ian R; Meyer, Jonathan; Nasrallah, Henry A; Nucifora, Frederick C Jr; Rothschild, Anthony J; Rubio, Jose M; Sajatovic, Martha; Sarpal, Deepak K; Schoretsanitis, Georgios; Shad, Mujeeb; Shelton, Charles; Sher, Leo; Singh, Balwinder; Surya, Sandarsh; Zarzar, Theodore R; Sanz, Emilio J; De Las Cuevas, Carlos
